Cyclopropylamine

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 1131 Experts worldwide ranked by ideXlab platform

Jan Szymoniak - One of the best experts on this subject based on the ideXlab platform.

Armin De Meijere - One of the best experts on this subject based on the ideXlab platform.

  • Scalable synthesis of (1-cyclopropyl)Cyclopropylamine hydrochloride.
    Beilstein journal of organic chemistry, 2011
    Co-Authors: Sergei I. Kozhushkov, Alexander F. Khlebnikov, Rafael R. Kostikov, Dmitrii S. Yufit, Armin De Meijere
    Abstract:

    1-Cyclopropylcyclopropanecarboxylic acid (2), which is accessible on a large scale (900 mmol) from 1-bromo-1-cyclopropylcyclopropane (1) in 64% yield (89% on a 12.4 mmol scale), has been subjected to a Curtius degradation employing the Weinstock protocol to furnish the N-Boc-protected (1-cyclopropyl)Cyclopropylamine 3 (76%). Deprotection of 3 with hydrogen chloride in diethyl ether gave the (1-cyclopropyl)Cyclopropylamine hydrochloride (4·HCl) in 87% yield.

  • Cyclopropylamines from N,N-Dialkylcarboxamides and Grignard Reagents in the Presence of Titanium Tetraisopropoxide or Methyltitanium Triisopropoxide.
    ChemInform, 2011
    Co-Authors: Armin De Meijere, Vladimir Chaplinski, Harald Winsel, Markus Kordes, Bjoern Stecker, Vesta Gazizova, Andrei I. Savchenko, Roland Boese, Farina Schill
    Abstract:

    Cyclopropylamines are successfully synthesized by the reaction of different substituted carboxamides with Grignard reagents in the presence of stoichiometric amounts of Me-Ti(O-iPr)3.

  • Cyclopropylamines from N,N‐Dialkylcarboxamides and Grignard Reagents in the Presence of Titanium Tetraisopropoxide or Methyltitanium Triisopropoxide
    Chemistry (Weinheim an der Bergstrasse Germany), 2010
    Co-Authors: Armin De Meijere, Vladimir Chaplinski, Harald Winsel, Markus Kordes, Bjoern Stecker, Vesta Gazizova, Andrei I. Savchenko, Roland Boese, Farina Schill
    Abstract:

    Thirty-three different N,N-dialkyl- and N-alkyl-N-phosphorylalkyl-substituted carboxamides 9-17 were treated with unsubstituted as well as with 2-alkyl-, 2,2-dialkyl-, and 3-alkenyl-substituted ethylmagnesium bromides 6 in the presence of stoichiometric amounts of titanium tetraisopropoxide or methyltitanium triisopropoxide to furnish substituted Cyclopropylamines 20-25 in 20-98% yield, depending on the substituents with no (1:1) to excellent (>25:1) diastereoselectivities. Generally higher yields (up to 98%) of the Cyclopropylamines 20-28 without loss of the diastereoselectivity were obtained with methyltitanium triisopropoxide as the titanium mediator. Under these conditions, even dioxolane-protected ketones and halogen-substituted and chiral as well as achiral alkyloxyalkyl-substituted carboxamides could be converted to the correspondingly substituted Cyclopropylamines with unsubstituted as well as phenyl- and a variety of alkyl-substituted ethylmagnesium bromides in addition to numerous heteroatom-containing (e.g., halogen-, trityloxy-, tetrahydropyranyloxy-substituted) Grignard reagents (62 examples altogether). The transformation of N,N-diformylalkylamines 54 with ethylmagnesium bromide in the presence of methyltitanium triisopropoxide to N,N-dicyclopropyl-N-alkylamines 55 can be brought about in up to 82% yield (6 examples). An asymmetric variant of the titanium-mediated cyclopropanation of N,N-dialkylcarboxamides has been developed by applying chiral titanium mediators generated from stoichiometric amounts of titanium tetraisopropoxide and chiral diamino or diol ligands, respectively. The most efficient chiral mediators turned out to be titanium bistaddolates that provided the corresponding Cyclopropylamines with enantiomeric excesses (ee) of up to 84%. Evaluation of several silyl-based additives revealed that the reaction can also efficiently be carried out with substoichiometric amounts (down to 25 mol%) of the titanium reagent, as long as 2-aryl- or 2-ethenyl-substituted ethylmagnesium halides are used and a concomitant slight decrease in yields is accepted. The newly developed methodology was successfully applied for the preparation of analogues with Cyclopropylamine moieties of known drugs and natural products such as the nicotine metabolite (S)-Cotinine as well as the insecticides Dinotefuran and Imidacloprid.

  • Titanium-mediated syntheses of Cyclopropylamines
    Journal of Organometallic Chemistry, 2004
    Co-Authors: Armin De Meijere, Sergei I. Kozhushkov, Andrei I. Savchenko
    Abstract:

    Abstract The transformations of N , N -dialkylcarboxamides and nitriles with 1,2-dicarbanionic organometallics in situ generated from organomagnesium (Grignard) as well as organozinc reagents in the presence of stoichiometric or substoichiometric (semi-catalytic) quantities of a titanium alkoxide derivative of type XTi(OR) 3 with X=OR, Cl, Me and OR=O i Pr, OEt are described. The key step in the transformation of a monocarbanionic into a 1,2-dicarbanionic organotitanium species is a disproportionation of a dialkyltitanium intermediate to form an alkane and a titanium alkene complex which has the reactivity of a titanacyclopropane derivative. The latter are able to undergo insertion of the carbonyl group of an N , N -dialkylcarboxamide or a cyano group to furnish, after ring contraction and hydrolysis, dialkylCyclopropylamines or Cyclopropylamines, respectively. The titanium alkene complexes can also undergo ligand exchange with alkenes to afford new titanacyclopropanes, which subsequently react as 1,2-dicarbanionic equivalents. In many cases, these titanium-mediated formations of a wide range of synthetically and/or pharmacologically important Cyclopropylamines proceed in good to very good yields (from 20% to 98% for dialkylCyclopropylamines from N , N -dialkylcarboxamides and from 27% to 73% for primary Cyclopropylamines from nitriles) and with high chemo- and stereoselectivity. These circumstances in conjunction with the simplicity of the experimental handling and inexpensiveness of the reagents favor these reactions for an ever increasing range of applications in organic synthesis.

  • Easy access to various substituted 4-aminocyclopentenes by rearrangement of 2-ethenyl-substituted Cyclopropylamines
    Journal of the Chemical Society Perkin Transactions 1, 1998
    Co-Authors: Craig M. Williams, Armin De Meijere
    Abstract:

    A variety of 2-ethenyl-substituted Cyclopropylamines upon flash vacuum pyrolysis or under silver nitrate catalysis cleanly undergo ring enlargement and afford high yields (up to 95%) of 4-aminocyclopent-1-enes, some of which have unprecedented substitution patterns.

Philippe Bertus - One of the best experts on this subject based on the ideXlab platform.

Mark Stradiotto - One of the best experts on this subject based on the ideXlab platform.

  • Nickel-Catalyzed N-Arylation of Cyclopropylamine and Related Ammonium Salts with (Hetero)aryl (Pseudo)halides at Room Temperature
    ACS Catalysis, 2017
    Co-Authors: Joseph P. Tassone, Preston M. Macqueen, Christopher M. Lavoie, Michael J. Ferguson, Robert Mcdonald, Mark Stradiotto
    Abstract:

    Whereas the metal-catalyzed C(sp2)–N cross-coupling of Cyclopropylamine with aryl electrophiles represents an attractive route to pharmaceutically relevant N-arylCyclopropylamines, few catalysts that are capable of effecting such transformations have been identified. Herein, the nickel-catalyzed C(sp2)–N cross-coupling of Cyclopropylamine and related nucleophiles, including ammonium salts, with (hetero)aryl (pseudo)halides is reported for the first time, with the demonstrated scope of reactivity exceeding that displayed by all previously reported catalysts (Pd, Cu, or other). Our preliminary efforts to effect the N-arylation of Cyclopropylamine with (hetero)aryl chlorides at room temperature by use of (L)NiCl(o-tolyl) precatalysts (L = PAd-DalPhos, C1; L = JosiPhos CyPF-Cy, C2) were unsuccessful, despite the established efficacy of C1 and C2 in transformations of other primary alkylamines. However, systematic modification of the ancillary ligand (L) structure enabled success in such transformations, with ...

  • Nickel-Catalyzed N‑Arylation of Cyclopropylamine and Related Ammonium Salts with (Hetero)aryl (Pseudo)halides at Room Temperature
    2017
    Co-Authors: Joseph P. Tassone, Preston M. Macqueen, Christopher M. Lavoie, Michael J. Ferguson, Robert Mcdonald, Mark Stradiotto
    Abstract:

    Whereas the metal-catalyzed C­(sp2)–N cross-coupling of Cyclopropylamine with aryl electrophiles represents an attractive route to pharmaceutically relevant N-arylCyclopropylamines, few catalysts that are capable of effecting such transformations have been identified. Herein, the nickel-catalyzed C­(sp2)–N cross-coupling of Cyclopropylamine and related nucleophiles, including ammonium salts, with (hetero)­aryl (pseudo)­halides is reported for the first time, with the demonstrated scope of reactivity exceeding that displayed by all previously reported catalysts (Pd, Cu, or other). Our preliminary efforts to effect the N-arylation of Cyclopropylamine with (hetero)­aryl chlorides at room temperature by use of (L)­NiCl­(o-tolyl) precatalysts (L = PAd-DalPhos, C1; L = JosiPhos CyPF-Cy, C2) were unsuccessful, despite the established efficacy of C1 and C2 in transformations of other primary alkylamines. However, systematic modification of the ancillary ligand (L) structure enabled success in such transformations, with crystallographically characterized (L)­NiCl­(o-tolyl) precatalysts incorporating o-phenylene-bridged bisphosphines featuring phosphatrioxaadamantane and PCy2 (L = L3, CyPAd-DalPhos; C3), P­(o-tolyl)2 and P­(t-Bu)2 (L = L4; C4), or PCy2 and P­(t-Bu)2 (L = L5; C5) donor pairings proving to be particularly effective. In employing the air-stable precatalyst C3 in cross-couplings of Cyclopropylamine, substituted electrophiles encompassing an unprecedentedly broad range of heteroaryl (pyridine, isoquinoline, quinoline, quinoxaline, pyrimidine, purine, benzothiophene, and benzothiazole) and (pseudo)­halide (chloride, bromide, mesylate, tosylate, triflate, sulfamate, and carbamate) structures were employed successfully, in the majority of cases under mild conditions (3 mol % of Ni, 25 °C). Preliminary studies also confirmed the ability of C3 to effect the N-arylation of cyclopropanemethylamine hydrochloride and cyclobutylamine hydrochloride under similar conditions. A notable exception in this chemistry was observed specifically in the case of electron-rich aryl chlorides, where the use of C4 in place of C3 proved more effective. In keeping with this observation, catalyst inhibition by 4-chloroanisole was observed in the otherwise efficient cross-coupling of Cyclopropylamine and 3-chloropyridine when using C3. Competition studies involving C3 revealed a (pseudo)­halide reactivity preference (Cl > Br, OTs)

Timothy L Macdonald - One of the best experts on this subject based on the ideXlab platform.

  • in vitro metabolism of a model Cyclopropylamine to reactive intermediate insights into trovafloxacin induced hepatotoxicity
    Chemical Research in Toxicology, 2008
    Co-Authors: Qin Sun, Ran Zhu, Frank W Foss, Timothy L Macdonald
    Abstract:

    Trovafloxacin (Trovan) is a fluoroquinolone antibiotic drug with a long half-life and broad-spectrum activity. Since its entry into the market in 1998, trovafloxacin has been associated with numerous cases of hepatotoxicity, which has limited its clinical usefulness. Trovafloxacin possesses two substructural elements that have the potential to generate reactive intermediates: a Cyclopropylamine moiety and a difluoroanilino system. The results presented here describe the in vitro metabolic activation of a synthetic drug model (DM) of trovafloxacin that contains the Cyclopropylamine moiety. Cyclopropylamine can be oxidized to reactive ring-opened products—a carbon-centered radical and a subsequently oxidized α,β-unsaturated aldehyde. Experiments with monoamine oxygenases, horseradish peroxidase, flavin monooxygenase 3, and cDNA-expressed P450 isoenzymes revealed that P450 1A2 oxidizes DM to a reactive α,β-unsaturated aldehyde, M1. Furthermore, myeloperoxidase (MPO) was also demonstrated to oxidize DM in the...

  • Mechanisms of trovafloxacin hepatotoxicity: studies of a model Cyclopropylamine-containing system.
    Bioorganic & medicinal chemistry letters, 2007
    Co-Authors: Qin Sun, Ran Zhu, Frank W Foss, Timothy L Macdonald
    Abstract:

    The mechanism for the hepatotoxicity of trovafloxacin remains unresolved. Trovafloxacin contains a Cyclopropylamine moiety which has a potential to be oxidized to reactive intermediate(s) although other putative elements may exist. In this study, a drug model of trovafloxacin containing the Cyclopropylamine substructure was synthesized. Chemical oxidation of the drug model by K3Fe(CN)6 and NaClO revealed that both oxidants oxidize this drug model to a reactive α,β-unsaturated aldehyde, 11. The structure of 11 was fully elucidated by LC/MS/MS and NMR analysis. These results suggested that P450s with heme-iron center and myeloperoxidase generating hypochlorous acid in the presence of chloride ion are capable of bioactivating the Cyclopropylamine moiety of trovafloxacin. This deleterious metabolism may lead to eventual hepatotoxicity.